Cargando…
Inhibiting Transglutaminase 2 Mediates Kidney Fibrosis via Anti-Apoptosis
Transglutaminase 2 (TG2) is a calcium-dependent transamidating acyltransferase enzyme of the protein-glutamine γ-glutamyltransferase family implicated in kidney injury. In this study, we identified associations between TG2 and chronic kidney disease (CKD) identified by visualizing TG2 in kidney biop...
Autores principales: | Moon, Jong-Joo, Choi, Yejin, Kim, Kyu-Hyeon, Seo, Areum, Kwon, Soie, Kim, Yong-Chul, Kim, Dong-Ki, Kim, Yon-Su, Yang, Seung-Hee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220123/ https://www.ncbi.nlm.nih.gov/pubmed/35740367 http://dx.doi.org/10.3390/biomedicines10061345 |
Ejemplares similares
-
Siglec-F–expressing neutrophils are essential for creating a profibrotic microenvironment in renal fibrosis
por: Ryu, Seungwon, et al.
Publicado: (2022) -
Target value of mean arterial pressure in patients undergoing continuous renal replacement therapy due to acute kidney injury
por: Kim, Yaerim, et al.
Publicado: (2021) -
Active maintenance of endothelial cells prevents kidney fibrosis
por: Yang, Seung Hee, et al.
Publicado: (2017) -
Urinary transglutaminase 2 as a potent biomarker to predict interstitial fibrosis and tubular atrophy of kidney allograft during early posttransplant period in deceased donor kidney transplantation
por: Kim, Jee Yeon, et al.
Publicado: (2019) -
Apolipoprotein B is a risk factor for end-stage renal disease
por: Kwon, Soie, et al.
Publicado: (2020)